Early Phase 1 Autoimmune Hemolytic Anemia Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia

AIHA - Warm Autoimmune Hemolytic AnemiaUCART

The Second Hospital of Anhui Medical University15 enrolled1 locationNCT07530380

Recruiting

Early Phase 1

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

Autoimmune Hemolytic AnemiaEvans SyndromePrimary Immune Thrombocytopenic Purpura

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology27 enrolled1 locationNCT07441525

Recruiting

Early Phase 1

Safety Study of CC312 in Autoimmune Disease Patients

Rheumatoid Arthritis (RA)Autoimmune Hemolytic AnemiaSystemic Lupus Erythematosus (SLE)+3 more

CytoCares Inc18 enrolled1 locationNCT06888960